Bullish Moving Averages
5
Bearish Moving Averages
11
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
58.20Today’s High
60.0052W low
48.5052W High
111.00Open Price
58.90Prev. Close
55.6000Volume
26997.00Value
1594172.85Fundamentals
Market Cap Cr
122.80
Price to Earnings
42.10
Price to Book Value
2.10
Dividend Yield
0.80
PE to Growth
-1.50
Op Revenue TTM Cr
48.21
Net Profit TTM Cr
2.91
Cash From Operating Activity Cr
5.68
Return on Equity %
4.90
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
04 Jul, 2024
69.6
Week
61.7
Month
61.5
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
59.09
PIVOT
First Resistance
59.96
Second Resistance
60.87
Third Resistance
61.74
First Support
58.18
Second Support
57.31
Third Support
56.40
Relative Strength Index
48.83
Money Flow Index
38.75
MACD
-0.34
MACD Signal
-0.17
Average True Range
3.03
Average Directional Index
28.3
Rate of Change (21)
12.58
Rate of Change (125)
-29.11
Commodity Channel Index
-22.9
Williams %R
-49.8
BETA
1 Month
0.8
3 Month
0.48
1 Year
0.6
3 Year
0.21
PRICE CHANGE ANALYSIS
↑ 0.49%
1 Week
Low
High
54.05
60.48
↑ 7.17%
1 Month
Low
High
52.35
64.38
↓ -4.91%
3 Months
Low
High
52.35
64.38
↓ -34.86%
6 Months
Low
High
48.5
95.6
↓ -27.1%
1 Year
Low
High
48.5
111
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 11.28 | 12.38 | 13.00 | 12.85 | 11.53 | 12.45 | 12.10 | 12.11 | 10.86 | 11.82 | 11.02 | |
| Operating Expenses Qtr | 10.13 | 10.45 | 10.92 | 10.19 | 9.78 | 10.02 | 10.11 | 9.55 | 9.32 | 9.25 | 8.72 | |
| Operating Profit Qtr | 0.76 | 1.58 | 1.81 | 2.38 | 1.39 | 2.12 | 1.75 | 2.33 | 1.25 | 2.35 | 2.09 | |
| EBIDT Qtr Cr | 1.16 | 1.92 | 2.09 | 2.67 | 1.75 | 2.43 | 1.98 | 2.56 | 1.53 | 2.57 | 2.30 | |
| Depreciation Qtr | 1.12 | 0.98 | 0.89 | 0.73 | 0.78 | 0.77 | 0.75 | 0.68 | 0.75 | 0.63 | 0.60 | |
| Net Profit Qtr | 0.02 | 0.66 | 0.85 | 1.38 | 0.65 | 1.16 | 0.90 | 1.37 | 0.54 | 1.39 | 1.25 | |
| Basic EPS Qtr | 0.01 | 0.32 | 0.41 | 0.67 | 0.31 | 0.56 | 0.43 | 0.66 | 0.26 | 0.67 | 0.60 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 49.51 | 48.19 | 39.80 | 33.11 | 41.45 | |
| Operating Expenses Annual Cr | 41.68 | 39.46 | 33.06 | 28.81 | 36.74 | |
| Operating Profit Annual | 6.53 | 7.59 | 5.85 | 3.56 | 3.81 | |
| Operating Profit Margin Annual % | 13.19 | 15.74 | 14.69 | 10.76 | 9.20 | |
| Total Expenses Annual Cr | 45.50 | 42.54 | 35.69 | 31.20 | 39.31 | |
| EBIDT Annual Cr | 7.83 | 8.73 | 6.73 | 4.31 | 4.71 | |
| EBIDT Annual margin % | 15.82 | 18.12 | 16.92 | 13.00 | 11.37 | |
| Depreciation | 3.73 | 2.98 | 2.50 | 2.33 | 2.50 | |
| PAT Before ExtraOrdinary Items Annual Cr | 2.91 | 4.08 | 2.98 | 1.57 | 1.06 | |
| Net Profit Annual | 2.91 | 4.08 | 2.98 | 1.57 | 1.06 | |
| Basic EPS Annual | 1.40 | 1.96 | 1.44 | 0.75 | 0.51 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 59.41 | 57.58 | 54.61 | 52.70 | 51.26 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 0.99 | 0.42 | 1.24 | 0.71 | 1.09 | |
| Total Current Liabilities Annual Cr | 6.23 | 5.19 | 5.75 | 5.82 | 6.10 | |
| Total Capital Plus Liabilities Annual Cr | 66.63 | 63.19 | 61.60 | 59.23 | 58.44 | |
| Fixed Assets Annual | 48.73 | 44.18 | 44.07 | 40.54 | 42.67 | |
| Total Non Current Assets Annual | 52.61 | 48.48 | 48.73 | 45.63 | 47.74 | |
| Total Current Assets Annual | 14.02 | 14.71 | 12.86 | 13.60 | 10.70 | |
| Total Assets Annual | 66.63 | 63.19 | 61.60 | 59.23 | 58.44 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 0.90 | 0.90 | 0.90 | 0.90 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 5.68 | 4.39 | 4.39 | 2.74 | 4.81 | |
| Cash from Investing Activity Annual | -4.63 | -2.19 | -3.92 | 0.49 | -0.53 | |
| Cash from Financing Annual Activity | -3.40 | -1.71 | -1.58 | -0.33 | 0.13 | |
| Net Cash Flow Annual | - | 0.49 | -1.10 | 2.90 | 4.42 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 28.57 | 27.69 | 26.26 | 25.34 | 24.65 | |
| ROE Annual % | 4.90 | 7.08 | 5.46 | 2.97 | 2.07 | |
| ROCE Annual % | 6.79 | 9.91 | 7.57 | 3.69 | 4.23 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 16.24 | 18.56 | 17.30 | 13.30 | 11.62 |
| Indicator | Graph |
|---|---|
| Total Qtr Revenue cr | |
| Operating Expenses Qtr | |
| Operating Profit Qtr | |
| EBIDT Qtr Cr | |
| Depreciation Qtr | |
| Net Profit Qtr | |
| Basic EPS Qtr |
| Indicator | Graph |
|---|---|
| Total Revenue Annual | |
| Operating Expenses Annual Cr | |
| Operating Profit Annual | |
| Operating Profit Margin Annual % | |
| Total Expenses Annual Cr | |
| EBIDT Annual Cr | |
| EBIDT Annual margin % | |
| Depreciation | |
| PAT Before ExtraOrdinary Items Annual Cr | |
| Net Profit Annual | |
| Basic EPS Annual |
| Indicator | Graph |
|---|---|
| Total ShareHolders Funds Annual | |
| Minority Interest Liability Annual Cr | |
| Total Non Current Liabilities Annual Cr | |
| Total Current Liabilities Annual Cr | |
| Total Capital Plus Liabilities Annual Cr | |
| Fixed Assets Annual | |
| Total Non Current Assets Annual | |
| Total Current Assets Annual | |
| Total Assets Annual | |
| Contingent Liabilities plus Commitments Annual Cr |
| Indicator | Graph |
|---|---|
| Cash from Operating Activity Annual | |
| Cash from Investing Activity Annual | |
| Cash from Financing Annual Activity | |
| Net Cash Flow Annual |
| Indicator | Graph |
|---|---|
| Book Value Per Share Annual | |
| ROE Annual % | |
| ROCE Annual % | |
| Total Debt to Total Equity Annual | |
| EBDIT Annual Margin % |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Sangeetha S | 18.84 | 74198261 | 0 | 0 |
| Kaliannagounder Sundaramoorthy | 2.41 | 74198262 | 0 | 0 |
| Kavetha Sundaramoorthy | 18.78 | 74198267 | 0 | 0 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Sangeetha S | 18.84 | 74198261 | 0 | 0 |
| Kaliannagounder Sundaramoorthy | 2.41 | 74198262 | 0 | 0 |
| S Rajkumar | 1.36 | 74198263 | 0 | 0 |
| Kavetha Sundaramoorthy | 18.78 | 74198267 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|---|---|
| Sangeeta Choudhary | 3.92 | 74198278 |
| Rajiv Choudhary | 3.03 | 74198279 |
| Mahendran Devika | 1.97 | 74198280 |
| Kalpesh Harakhchand Gala | 1.09 | 74198281 |
| HUF | 1.5 | 74198270 |
| Kovai Purani Finance Private Limited | 6.33 | 74198274 |
| Vramath Investment Consultancy Pvt Ltd | 4.84 | 74198275 |
| K S Ramalingam | 1.43 | 74198284 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Sep 18, 2023 | 0.5 | FINAL | - | Equity Share |
| Sep 08, 2022 | 0.5 | FINAL | Sep 10, 2022 | Equity Share |
| Sep 08, 2021 | 0.5 | FINAL | - | Equity Share |
| Sep 14, 2018 | 0.5 | FINAL | - | Equity Share |
| Aug 02, 2017 | 0.5 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| Aug 14, 2023 | Quarterly Results | - |
| May 24, 2023 | Audited Results & Dividend | - |
| Feb 13, 2023 | Quarterly Results | - |
| Nov 14, 2022 | Audited Results | - |
| Aug 09, 2022 | Quarterly Results | - |
| May 25, 2022 | Audited Results & Final Dividend | - |
| Feb 14, 2022 | Quarterly Results | - |
| Nov 13, 2021 | Quarterly Results | - |
| Aug 14, 2021 | Quarterly Results | - |
| Jun 30, 2021 | Audited Results & Final Dividend | - |
| Feb 09, 2021 | Quarterly Results | - |
| Nov 11, 2020 | Quarterly Results | - |
| Sep 24, 2020 | Others | - |
| Aug 31, 2020 | Quarterly Results | - |
| Jul 30, 2020 | Audited Results | - |
| Jun 29, 2020 | Audited Results | - |
| Feb 06, 2020 | Quarterly Results | - |
| Jan 13, 2020 | Others | inter alia, 1. To appoint the chief financial officer of the company. 2. To consider any other matters with the permission of the chair |
| Nov 14, 2019 | Quarterly Results | - |
| Aug 12, 2019 | Quarterly Results | - |
| May 28, 2019 | Audited Results & Dividend | - |
| Feb 05, 2019 | Quarterly Results | - |
| Nov 12, 2018 | Quarterly Results | - |
| Aug 08, 2018 | Quarterly Results | - |
| May 29, 2018 | Audited Results & Dividend | - |
| Feb 12, 2018 | Quarterly Results | - |
| Nov 14, 2017 | Quarterly Results | - |
| Aug 10, 2017 | Quarterly Results | - |
| May 27, 2017 | Audited Results & Dividend | - |
| Jan 31, 2017 | Quarterly Results | - |
| Nov 14, 2016 | Quarterly Results | Appointment of Dr. S. Rajkumar, who is a relative of director(s) of the Company as a Vice-President - Qualityw.e.f. September 14, 2016 on the remuneration not exceeding Rs. 2,50,000.00 p.m. |
| Aug 13, 2016 | Quarterly Results | - |
| May 30, 2016 | Audited Results | Appointment of Mr. Aditya Sharma as a Company Secretary of the Company and as Key Managerial personnel pursuant to section 203 of the Companies Act. 2013 and also be the Compliance Officer. |
| Feb 14, 2016 | Quarterly Results | - |
| Nov 13, 2015 | Quarterly Results | - |
| Aug 12, 2015 | Quarterly Results | - |
| May 30, 2015 | Audited Results | - |
| Feb 14, 2015 | Quarterly Results | - |
| Jan 14, 2015 | Quarterly Results | - |
| Nov 14, 2014 | Quarterly Results | - |
| Aug 13, 2014 | Quarterly Results | - |
| May 24, 2014 | Audited Results | - |
| Feb 04, 2014 | Quarterly Results | - |
| Nov 06, 2013 | Quarterly Results | - |
| May 24, 2013 | Audited Results | - |
| Feb 14, 2013 | Quarterly Results | - |
| Nov 10, 2012 | Quarterly Results | - |
| Aug 07, 2012 | Audited & Quarterly Results | - |
| May 28, 2012 | Audited Results | - |
| Feb 09, 2012 | Quarterly Results | - |
| Nov 10, 2011 | Quarterly Results | - |
| Aug 04, 2011 | Audited & Quarterly Results | - |
| May 24, 2011 | Audited Results | - |
| Feb 15, 2011 | Quarterly Results | - |
| Nov 15, 2010 | Quarterly Results | - |
| Aug 10, 2010 | Audited & Quarterly Results | - |
| May 26, 2010 | Audited Results | (Revised) |
| Jan 27, 2010 | Quarterly Results | - |
| Oct 27, 2009 | Quarterly Results | - |
| Jul 29, 2009 | Quarterly Results | - |
| Jul 27, 2009 | Quarterly Results | - |
| Apr 29, 2009 | Quarterly Results | (Revised) |
| Jan 28, 2009 | Quarterly Results | - |
| Oct 29, 2008 | Quarterly Results | - |
| Jul 31, 2008 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
28 Jun 2024
Lotus Eye Hospital And Institute Ltd - 532998 - Closure of Trading Window
The trading window shall remain closed from 01st July 2024 till 48 hours after the declaration of unaudited financial results for the quarter and year ended June 30th 2024
12 Jun 2024
Lotus Eye Hospital And Institute Ltd - 532998 - Inauguration Of New Center Of Lotus Eye Hospital And Institute Limited At Karur Tamilnadu
We are pleased to inform the opening of 09th center of Lotus Eye Hospital and Institute Limited at Karur Tamil Nadu
29 May 2024
Lotus Eye Hospital And Institute Ltd - 532998 - Compliances-Reg.24(A)-Annual Secretarial Compliance
The report is for the Financial year 2023-24
28 May 2024
Lotus Eye Hospital And Institute Ltd - 532998 - Announcement under Regulation 30 (LODR)-Newspaper Publication
The Advertisement of the financial results in The Tamil Hindu (Coimbatore Edition) and Business standard (All India Edition) on 28th May 2024.
27 May 2024
Lotus Eye Hospital And Institute Ltd - 532998 - Financial Results For The Quarter And Year Ended 31St March 2024
The Board of directors of Lotus Eye Hospital and Institute Limited approved the audited financial results for the quarter and financial year ended 31st march 2024
27 May 2024
Lotus Eye Hospital And Institute Ltd - 532998 - Outcome Of Board Meeting Held On 27Th May 2024
The Board of Directors of Lotus Eye Hospital and Institute Limited approved the audited standalone financial results for the quarter and financial year ended 31st March 2024
22 May 2024
Lotus Eye Hospital And Institute Ltd - 532998 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47(1)(d) of SEBI LODR 2015 notice to shareholders
03 May 2024
Lotus Eye Hospital And Institute Ltd - 532998 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 02, 2024 for S Rajkumar
20 Apr 2024
Lotus Eye Hospital And Institute Ltd - 532998 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyLotus Eye Hospital And Institute Ltd 2CIN NO.L85110TZ1997PLC007783 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY Nil 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: M Achuth menon Designation: Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: Reghunathan Ramanujam Designation: Chief Financial Officer EmailId: [email protected] Date: 20/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
16 Apr 2024
Lotus Eye Hospital And Institute Ltd - 532998 - Certificate Under Regulation 40(9) Of SEBI LODR 2015
Pursuant to Regulation 40(10) we hereby attach the certificate issued by a practicing company secretary under Regulation 40(9) of SEBI LODR 2015
